Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Scientific Reports|September 15, 2021
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville KentuckyKrystal T Hamorsky, Adrienne M Bushau-Sprinkle, Kathleen Kitterman, et al.American Journal of Hematology|February 3, 2015
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)Kami Maddocks, Lai Wei, Darlene Rozewski, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2018
Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney diseaseChristian Lerch, Rukshana Shroff, Mandy Wan, et al.Blood|May 15, 2015
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activationTa-Ming Liu, Jennifer A Woyach, Yiming Zhong, et al.Leukemia & Lymphoma|September 13, 2014
A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphomaCraig C Hofmeister, Nita Williams, Susan Geyer, et al.Journal of the American Society of Nephrology : JASN|April 25, 2009
HNF1B mutations associate with hypomagnesemia and renal magnesium wastingShazia Adalat, Adrian S Woolf, Karen A Johnstone, et al.Leukemia & Lymphoma|March 9, 2017
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomasDouglas W Sborov, Alessandro Canella, Erinn M Hade, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 7, 2021
Mortality in Children Treated With Maintenance Peritoneal Dialysis: Findings From the International Pediatric Peritoneal Dialysis Network RegistrySophie Ploos van Amstel, Marlies Noordzij, Dagmara Borzych-Duzalka, et al.Blood|January 14, 2014
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapyJennifer A Woyach, Kelly Smucker, Lisa L Smith, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 24, 2014
Adolescent and young adult oncology, version 2.2014Peter F Coccia, Alberto S Pappo, Jessica Altman, et al.Pageof 15